TDY Teledyne Technologies

Research status: Primary-source refreshed through the Sep 2026 investor update and the announced $1.1B Varex Imaging acquisition. Valuation reference: $612.02 close on 24 Sep 2026, up ~22% from the August dossier reference.

TDY remains the highest-quality, least binary defence name in the current comparison set, but the expected-return setup has become less attractive as the share price rose. The most important new event is capital allocation: Teledyne agreed to acquire Varex Imaging for approximately $1.1B including net debt, adding X-ray sources, detectors, high-voltage interconnects and imaging software across medical, industrial and security end markets. The deal fits Teledyne's long-running imaging/M&A playbook and should broaden Digital Imaging, but it also consumes balance-sheet capacity and raises the hurdle for post-deal ROIC.

The core defence thesis remains intact: FLIR thermal imaging, Black Hornet nano-UAS, infrared sensors and aerospace/defence electronics continue to provide durable exposure, while the portfolio structure limits single-program risk. But at $612, TDY no longer offers the same margin of safety that existed near $504 in August.

PowerFund's refreshed 24-month probability-weighted working value is approximately $690/share, implying only about 6% annualized from the current price. TDY therefore remains a high-quality watchlist candidate, but it is not currently competitive for new Defence capital versus higher-expected-return alternatives unless either the valuation resets or the Varex/defence growth outlook proves materially better than the current base case.

Investment case

Teledyne owns a portfolio of high-value sensing, imaging, aerospace/defence electronics and instrumentation businesses with long qualification cycles, mission-critical applications and disciplined capital allocation.

> The PowerFund thesis is that Teledyne can compound per-share value through mid/high-single-digit organic growth, strong cash conversion and high-return acquisitions, while FLIR and aerospace/defence electronics provide structural tailwinds. The Varex deal fits that model strategically, but at the current share price the expected return is no longer high enough to justify prioritizing TDY over cheaper Defence opportunities.

New capital-allocation evidence

• Teledyne agreed to acquire Varex Imaging for ~$1.1B including net debt.
• Varex adds X-ray tubes, detectors, high-voltage interconnects and imaging software across medical, industrial/security and inspection markets.
• The deal broadens Digital Imaging and creates potential technology/customer synergies, but the key question is whether Teledyne earns attractive post-deal ROIC after financing/integration costs.

Defence baseline remains intact

• FLIR thermal/infrared imaging and unmanned systems remain strong franchises.
• Black Hornet continues to demonstrate international defence demand and embedded operational use.
• Aerospace & Defense Electronics and infrared sensing provide broader defence exposure with less binary program risk than KTOS-style names.

Updated valuation scenarios

These are PowerFund estimates, not company guidance.

24 months

Probability-weighted midpoint: ~$690/share. At $612.02, weighted 24-month CAGR is roughly 6%.

60 months

TDY still has a valuable portfolio role as Defence quality ballast, but the present valuation does not offer the mid-teens base-case return hurdle PowerFund seeks for new capital.

• Varex closing and evidence of accretive integration without leverage stress.
• Continued defence demand for thermal imaging, Black Hornet and aerospace/defence electronics.
• Organic acceleration in Digital Imaging / A&D Electronics.
• Strong FCF conversion and rapid post-deal deleveraging.
• Additional disciplined bolt-on M&A after leverage normalizes.
• Material price dislocation without deterioration in the long-term thesis.

• Valuation: current price offers limited expected-return margin under the base case.
• Varex integration / ROIC: $1.1B of capital must generate attractive incremental earnings and cash flow.
• M&A dependence: poor capital allocation would damage the core compounder thesis.
• Leverage: the Varex transaction temporarily reduces balance-sheet flexibility.
• Industrial/medical cyclicality: instrumentation and imaging end markets can soften.
• Defence procurement timing: growth can be uneven despite strong long-term demand.
• Opportunity cost: TDY may be a better business but a worse investment than cheaper Defence names at a given price.

Warning — freeze additions

• Organic growth falls below ~3% for multiple quarters without a clear cyclical explanation.
• Varex economics imply weak ROIC or materially slower deleveraging than expected.
• FCF conversion deteriorates after the transaction.
• Operating margins compress >150–200 bps without temporary mix/integration explanation.

Reduce / pass

• Varex integration consumes materially more capital than expected or fails to add per-share value.
• Digital Imaging and A&D Electronics underperform while the valuation remains premium.
• Capital allocation shifts toward expensive acquisitions without clear ROIC discipline.

Invalidate

> Invalidate if Teledyne loses its compounder characteristics: durable organic growth, strong cash conversion and disciplined acquisition returns.

Hard invalidators include material governance/accounting issues, persistent leverage stress, or evidence that FLIR / core sensing franchises are structurally losing competitive position.

TDY remains differentiated by portfolio quality and diversification, not maximum defence beta.

• KTOS: much higher growth and program/production optionality, but materially higher execution/cash-conversion/dilution risk.
• AVAV: stronger autonomous/counter-UAS/direct-energy growth and backlog, but greater acquisition/integration and program risk.
• MRCY: cheaper turnaround with larger execution uncertainty.
• TDY: strongest cash-generation/history and lowest thesis fragility, but currently the weakest near-term expected-return setup of the group at the present valuation.

This makes TDY a useful benchmark: a new Defence investment should either offer TDY-like quality at a better price or enough additional growth/return to compensate for higher fragility.

1. Build a 5-year segment model for Digital Imaging, Instrumentation and A&D Electronics, explicitly incorporating Varex after closing.
2. Track Varex purchase accounting, debt funding, synergies and post-deal net leverage / deleveraging.
3. Quantify FLIR defence versus commercial mix and Black Hornet contribution where disclosure permits.
4. Track organic growth separately from acquisitions by segment.
5. Reconcile adjusted EPS to GAAP earnings and FCF each quarter.
6. Compare TDY with KTOS, AVAV and MRCY on expected return, factor diversification, margin quality, cash conversion and capital intensity.
7. Reassess entry only if the stock falls enough to restore at least a low/mid-teens base-case expected return or if normalized earnings power is materially revised upward.

Next full review: after Q3 2026 results, Varex closing/financing details, or a material defence/imaging catalyst.